Eye Laser Industry Sees Minimal Impact From FDA LASIK Panel Meeting
This article was originally published in The Gray Sheet
Executive Summary
Laser vision correction device makers likely will not see major, direct fallout from a recent FDA panel meeting examining patient quality-of-life issues following laser-assisted in situ keratomileusis (LASIK), according to industry